12:00 AM
Jan 09, 2012
 |  BC Week In Review  |  Company News  |  Deals

Lightlake Therapeutics, King's College London deal

Lightlake and researchers at the university are in negotiations to develop a naloxone spray to prevent heroin overdose deaths. Lightlake's...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >